sechenovSechenov Medical JournalСеченовский вестник2218-73322658-3348Сеченовский Университетsechenov-706Research ArticleUROLOGYУРОЛОГИЯAn experience of radiofrequency ablation in the treatment of renal cell carcinomaОпыт применения радиочастотной абляции в лечении почечно-клеточного ракаГлыбочкоП. В.GlybochkoP. V.

д.м.н., член-корр. РАМН, профессор, ректор

MD, corresp. member of RAMS, prof., rector

АляевЮ. Г.AlyaevYu. G.

Юрий Геннадьевич Аляев, д.м.н., член-корр. РАМН, профессор, заслуженный деятель науки РФ, директор НИИ уронефрологии и репродуктивного здоровья человека, заведующий кафедрой урологии

119435, г. Москва, ул. Б. Пироговская, д. 2, стр. 1

8 (499) 248–71–00

Yury Gennadievich Alyaev, MD, corresp. member of RAMS, prof., honored scientist of RF, director of the Research centre of uronephrology and reproductive health, head of the chair of urology

2–1 B. Pirogovskaya str., Moscow, 119435

8 (499) 248–71–00

avinarov@mail.ruКондрашинС. А.KondrashinS. A.

д.м.н., профессор кафедры лучевой диагностики и лучевой терапии

MD, prof. of the chair of beam diagnostics and radiotherapy

СорокинН. И.SorokinN. I.

к.м.н., заведующий урологическим отделением УКБ № 2

PhD, head of the urology department of the University Hospital № 2

ШпотьЕ. В.Shpot’E. V.

к.м.н., доцент кафедры урологии

PhD, associate prof. of the chair of urology

МартиросянГ. А.MartirosyanG. A.

врач-уролог УКБ № 2

urologist of the University Hospital № 2

Первый МГМУ им. И.М. СеченоваРоссияI.M. Sechenov First MSMURussian Federation20143006201402515Copyright © Glybochko P.V., Alyaev Y.G., Kondrashin S.A., Sorokin N.I., Shpot’ E.V., Martirosyan G.A., 20142014Глыбочко П.В., Аляев Ю.Г., Кондрашин С.А., Сорокин Н.И., Шпоть Е.В., Мартиросян Г.А.Glybochko P.V., Alyaev Y.G., Kondrashin S.A., Sorokin N.I., Shpot’ E.V., Martirosyan G.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.sechenovmedj.com/jour/article/view/706

Radiofrequency ablation is a minimally invasive treatment for local destruction, widely used in the combined treatment of kidney cancer. Application of radiofrequency ablation allowed to expand the indications for more radical treatment of kidney tumors in patients who may not perform traditional nephrectomy or partial nephrectomy due to extremely burdened somatic status. Efficacy and safety of RFA greatly increased when it is combined with presuperselective occlusion of blood vessels that feed the tumor. We have experience in the use of superselective embolization in combination with RFA when a kidney tumor is in two patients. In both observations obtained good results of combined treatment. In some patients, this combination (CCE + RFA) may be an alternative to open surgery, thus expanding the range of modern minimally invasive treatments for kidney tumors.

Радиочастотная абляция является малоинвазивным методом локальной деструкции, широко применяемым в комбинированном лечении рака почки. Применение радиочастотной абляции позволило расширить показания к более радикальному лечению новообразований почки у пациентов, которым невозможно выполнение традиционной нефрэктомии или резекции почки, вследствие крайне отягощенного соматического статуса. Эффективность и безопасность РЧА значительно повышаются при ее сочетании с предварительной суперселективной окклюзией сосудов, питающих опухоль. Мы обладаем опытом применения суперселективной эмболизации в комбинации с РЧА при опухоли почки у двух пациентов. В обоих наблюдениях получен хороший результат комбинированного лечения. У ряда пациентов такая комбинация (CCЭ +РЧА) может являться альтернативой открытой операции, расширяя тем самым арсенал современных малоинвазивных методов лечения опухоли почки.

урологияпочечно-клеточный ракрадиочастотная абляцияurologyrenal-cell carcinomaradiofrequency ablationReferencesЗлокачественные новообразования в России в 2008 г. (заболеваемость и смертность) / Под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петровой. М. ФГУ «МНИОИ им. П.А. Герцена Росмедтехнологий». 2010.Malignancies in Russia in 2008 (morbidity and mortality) / Ed. by V.I. Chissov, V.V. Starinsky, G.V. Petrova. M. FSU «MSROI named after P.A. Herzen Rosmedtechnology». 2010.Павлов А.Ю., Клименко А.А., Момджан Б.К., Иванов С.А. Радиочастотная интерстициальная термоабляция (РЧА) рака почки // Экспериментальная и клиническая урология. 2011; 2–3: 112–113.Pavlov A.Yu., Klimemko A.A., Momdzhan B.K., Ivanov S.A. Radiofrequency interstitial thermoablation (RFA) of renal cancer // Eksperimental’naya i klinicheskaya urologiya. 2011; 2–3: 112–113.European Network of Cancer Registries. Eurocim version 4.0. European incidence database V2.3, 730 entity dictionary (2001), Lyon, 2001.European Network of Cancer Registries. Eurocim version 4.0. European incidence database V2.3, 730 entity dictionary (2001), Lyon, 2001.Chow W.H., Devesa S.S., Warren J.L., Freumeni J.F.Jr. Rising incidence of renal cell carcer in the United States // JAMA 1999; 281: 1628-31.Chow W.H., Devesa S.S., Warren J.L., Freumeni J.F.Jr. Rising incidence of renal cell carcer in the United States // JAMA 1999; 281: 1628-31.Nguyen M.M., ill I.S., Ellison L.M. The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program // J. Urol. 2006; 176: 2397-400; discussion 2400.Nguyen M.M., ill I.S., Ellison L.M. The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program // J. Urol. 2006; 176: 2397-400; discussion 2400.Kummerlin I.P., ten Kate F.J., Wij kstra H., de la Rosette J.J., Laguna M.P. Changes in the stage and surgical management of renal tumours during 1995-2005: an analysis of the Dutch national histopathology registry // BJU Int. 2008 Sep; 102(8): 946-51. Epub 2008 Jun 28.Kummerlin I.P., ten Kate F.J., Wij kstra H., de la Rosette J.J., Laguna M.P. Changes in the stage and surgical management of renal tumours during 1995-2005: an analysis of the Dutch national histopathology registry // BJU Int. 2008 Sep; 102(8): 946-51. Epub 2008 Jun 28.Ankem M.K., Nakada S.Y. Needle-nephron-sparing surgery // BJU Int. 2005; 95 (Suppl 2): 46-51.Ankem M.K., Nakada S.Y. Needle-nephron-sparing surgery // BJU Int. 2005; 95 (Suppl 2): 46-51.Havranek E., Anderson C. Future prospects for nephron conservation in renal cell carcinoma. In: Kirby R.S., O’Leary M.P., editors. Hot topics in urology. Amsterdam, The Netherlands: Elsevier, 2004; pp. 227-38.Havranek E., Anderson C. Future prospects for nephron conservation in renal cell carcinoma. In: Kirby R.S., O’Leary M.P., editors. Hot topics in urology. Amsterdam, The Netherlands: Elsevier, 2004; pp. 227-38.Marberger M., Mauerman J. Energy ablation nephronsparing treatment of renal tumors // AUA Update Series 2004; 23: 178-83.Marberger M., Mauerman J. Energy ablation nephronsparing treatment of renal tumors // AUA Update Series 2004; 23: 178-83.Reddan D.N., Raj G.V., Polascik T.J. Management of small renal tumors: an overview // Am. J. Med. 2001; 110: 558-62.Reddan D.N., Raj G.V., Polascik T.J. Management of small renal tumors: an overview // Am. J. Med. 2001; 110: 558-62.Weld K.J., Landman L. Comparison of cryoablation, radiofrequency ablation and high-intensity focused ultrasound for treating small renal tumors // BJU Int. 2005; 96: 1224-9.Weld K.J., Landman L. Comparison of cryoablation, radiofrequency ablation and high-intensity focused ultrasound for treating small renal tumors // BJU Int. 2005; 96: 1224-9.Uzzo R.G., Novick A.C. Nephron sparing surgery for renal tumors: indications techniques and outcomes // J. Urol. 166: 6–18.Uzzo R.G., Novick A.C. Nephron sparing surgery for renal tumors: indications techniques and outcomes // J. Urol. 166: 6–18.Долгушин Б.И., Косырев В.Ю., Рампрабанант С. Радиочастотная аблация в онкологии // Практическая онкология. 2007; 8 (4): 219–227.Dolgushin B.I., Kosyrev V.Yu., Ramprabanant S. Radiofrequency ablation in oncology // Prakticheskaya onkologiya. 2007; 8 (4): 219–227.Vogl T.J., Helmberger T.K., Mack M.G., Reiser M.F. (Eds.) Percutaneous Tumor Ablation in Medical Radiology. ISBN 978-3-540-22518-8 Springer. Berlin, Heidelberg, New York, 2008)Vogl T.J., Helmberger T.K., Mack M.G., Reiser M.F. (Eds.) Percutaneous Tumor Ablation in Medical Radiology. ISBN 978-3-540-22518-8 Springer. Berlin, Heidelberg, New York, 2008)Hal W.H., McGahan J.P., Link D.P., deVere White R.W. Combined Embolization and Percutaneous Radiofrequency Ablation of a Solid Renal Tumor // AJR 2000; 174: 1592-1594.Hal W.H., McGahan J.P., Link D.P., deVere White R.W. Combined Embolization and Percutaneous Radiofrequency Ablation of a Solid Renal Tumor // AJR 2000; 174: 1592-1594.Yamakado K., Nakatsuka A., Kobayashi S., Akeboshi M., Takaki H., Kariya Z., Kinbara H., Arima K., Yanagawa M., Hori Y., Kato H., Sugimura Y., Takeda K. //Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience // Cardiovasc Intervent Radiol. 2006 May-Jun; 29(3): 389-94.Yamakado K., Nakatsuka A., Kobayashi S., Akeboshi M., Takaki H., Kariya Z., Kinbara H., Arima K., Yanagawa M., Hori Y., Kato H., Sugimura Y., Takeda K. //Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience // Cardiovasc Intervent Radiol. 2006 May-Jun; 29(3): 389-94.Klingler H.C., Marberger M., Mauermann J. et al. ’Skipping’ is still a problem with radiofrequency ablation of small renal tumours // BJU Int. 2007; 99: 998–1001.Klingler H.C., Marberger M., Mauermann J. et al. ’Skipping’ is still a problem with radiofrequency ablation of small renal tumours // BJU Int. 2007; 99: 998–1001.Goldberg S.N., Gazelle G.S., Mueller P.R. Thermal ablation therapy for focal malignancy: A unifi ed approach to underlying principles, techniques and diagnostic imaging guidance // Am. J. Roentgenol. 2000; 174: 323-31.Goldberg S.N., Gazelle G.S., Mueller P.R. Thermal ablation therapy for focal malignancy: A unifi ed approach to underlying principles, techniques and diagnostic imaging guidance // Am. J. Roentgenol. 2000; 174: 323-31.Lee M. Ellis, Steven A. Curley, Kenneth K. Tanabe. Radiofrequency Ablation for Cancer.Current Indications, Techniques, and Outcomes. 2004 Springer-Verlag. New York, Inc.Lee M. Ellis, Steven A. Curley, Kenneth K. Tanabe. Radiofrequency Ablation for Cancer.Current Indications, Techniques, and Outcomes. 2004 Springer-Verlag. New York, Inc.Salagierski M., Salagierski M. Radiofrequency ablation partial nephrectomy: a new method of nephron-sparing surgery in selected patients // Int. J. Urol. 2006 Nov; 13(11): 1456-9.Salagierski M., Salagierski M. Radiofrequency ablation partial nephrectomy: a new method of nephron-sparing surgery in selected patients // Int. J. Urol. 2006 Nov; 13(11): 1456-9.Veltri A., Garetto I., Pagano E., Tosetti I., Sacchetto P., Fava C. Percutaneous RF termal ablation of renal tumors: is US guidance really less favorable than other imaging guidance techniques? // Cardiovasc Intervent Radiol. 2009 Jan; 32(1): 76-85. Epub 2008 Aug 15.Veltri A., Garetto I., Pagano E., Tosetti I., Sacchetto P., Fava C. Percutaneous RF termal ablation of renal tumors: is US guidance really less favorable than other imaging guidance techniques? // Cardiovasc Intervent Radiol. 2009 Jan; 32(1): 76-85. Epub 2008 Aug 15.Schirmang T.C., Mayo-Smith W.W., Dupuy D.E., Beland M.D., Grand D.J. Kidney neoplasms: renal halo sign after percutaneous radiofrequency ablation-incidence and clinical importance in 101 consecutive patients // Radiology. 2009 Oct; 253(1): 263-9. Epub 2009 Jul 31.Schirmang T.C., Mayo-Smith W.W., Dupuy D.E., Beland M.D., Grand D.J. Kidney neoplasms: renal halo sign after percutaneous radiofrequency ablation-incidence and clinical importance in 101 consecutive patients // Radiology. 2009 Oct; 253(1): 263-9. Epub 2009 Jul 31.Varkarakis I.M., Allaf M.E., Inagaki T., Bhayani S.B., Chan D.Y., Su L.M., Jarrett T.W., Kavoussi L.R., Solomon S.B. Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup // J. Urol. 2005 Aug; 174(2): 456-60; discussion 460.Varkarakis I.M., Allaf M.E., Inagaki T., Bhayani S.B., Chan D.Y., Su L.M., Jarrett T.W., Kavoussi L.R., Solomon S.B. Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup // J. Urol. 2005 Aug; 174(2): 456-60; discussion 460.Gervais D.A., McGovern F.J., Arellano R.S., McDougal W.S., Mueller P.R. Radiofrequency ablation of renal cell carcinoma: part1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors // AJR Am J Roentgenol. 2005 Jul; 185(1): 64-71.Gervais D.A., McGovern F.J., Arellano R.S., McDougal W.S., Mueller P.R. Radiofrequency ablation of renal cell carcinoma: part1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors // AJR Am J Roentgenol. 2005 Jul; 185(1): 64-71.Zagoria R.J., Traver M.A., Werle D.M., Perini M., Hayasaka S., Clark P.E., Oncologic Effi cacy of CT-Guided Percutaneous Radiofrequency Ablation of Renal Cell Carcinomas // Interventional Radiology. AJR: 189, August 2007.Zagoria R.J., Traver M.A., Werle D.M., Perini M., Hayasaka S., Clark P.E., Oncologic Effi cacy of CT-Guided Percutaneous Radiofrequency Ablation of Renal Cell Carcinomas // Interventional Radiology. AJR: 189, August 2007.Stern J.M., Gupta A., Raman J.D., Cost N., Lucas S., Lotan Y., Raj G.V., Cadeddu J.A. Radiofrequency ablation of small renal cortical tumours in healthy adults: renal function preservation and intermediate oncological outcome // BJU Int. 2009, 104, 786-789.Stern J.M., Gupta A., Raman J.D., Cost N., Lucas S., Lotan Y., Raj G.V., Cadeddu J.A. Radiofrequency ablation of small renal cortical tumours in healthy adults: renal function preservation and intermediate oncological outcome // BJU Int. 2009, 104, 786-789.Carey R.I., Leveillee R.J. First prize: direct real-time temperature monitoring for laporoscopic and CT-guided radiofrequency ablation of renal tumors between 3 and 5 cm // J. Endourol. 2007 Aug; 21(8): 807-13.Carey R.I., Leveillee R.J. First prize: direct real-time temperature monitoring for laporoscopic and CT-guided radiofrequency ablation of renal tumors between 3 and 5 cm // J. Endourol. 2007 Aug; 21(8): 807-13.Messerli F.H., Grossman E. Management of small renal tumors: an overview // Am J Med 2001; 110: 558–562.Messerli F.H., Grossman E. Management of small renal tumors: an overview // Am J Med 2001; 110: 558–562.Joniau S., Tailly T., Goeman L., Blyweert W., Gontero P., Joyce A. Kidney radiofrequency ablation for small renal tumors: oncologic effi cacy // J Endourol. 2010 May; 24(5): 721-8.Joniau S., Tailly T., Goeman L., Blyweert W., Gontero P., Joyce A. Kidney radiofrequency ablation for small renal tumors: oncologic effi cacy // J Endourol. 2010 May; 24(5): 721-8.Hegarty N.J., Gill I.S., Desai M.M., Remer E.M., O'Malley C.M., Kaouk J.H. Probe-ablative nephronsparing surgery: cryoablation versus radiofrequency ablation // Urology. 2006 Jul; 68(1 Suppl): 7-13.Hegarty N.J., Gill I.S., Desai M.M., Remer E.M., O'Malley C.M., Kaouk J.H. Probe-ablative nephronsparing surgery: cryoablation versus radiofrequency ablation // Urology. 2006 Jul; 68(1 Suppl): 7-13.Breen D.J., Rutherford E.E., Stedman B., Roy-Choudhury S.H., Cast J.E., Hayes M.C., Smart C.J. Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors // Cardiovasc Intervent Radiol. 2007 Sep-Oct; 30(5): 936-42. Epub 2007 Jun 18.Breen D.J., Rutherford E.E., Stedman B., Roy-Choudhury S.H., Cast J.E., Hayes M.C., Smart C.J. Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors // Cardiovasc Intervent Radiol. 2007 Sep-Oct; 30(5): 936-42. Epub 2007 Jun 18.Farrell M.A., Di Marco D.C. Imaging-guided radiofrequency ablation of solid renal tumors // AJR Amer. J. Roentgenol. 2003. Vol. 180. P. 1509.Farrell M.A., Di Marco D.C. Imaging-guided radiofrequency ablation of solid renal tumors // AJR Amer. J. Roentgenol. 2003. Vol. 180. P. 1509.Gervais D.A., Arellano R.S., McGovern F.J. et al. Radiofrequency ablation of renal cell carcinoma: part 2. Lessons learnedwith ablation of 100 tumors // AJR Amer. J. Roentgenol. 2005. Vol.185. P.72-80.Gervais D.A., Arellano R.S., McGovern F.J. et al. Radiofrequency ablation of renal cell carcinoma: part 2. Lessons learnedwith ablation of 100 tumors // AJR Amer. J. Roentgenol. 2005. Vol.185. P.72-80.Mahnken A.H., Gunther R.W., Tacke J. Radiofrequency ablation of renal Tumors // Europ. Radiol. 2004. Vol. 14(8). P.1449-1455.Mahnken A.H., Gunther R.W., Tacke J. Radiofrequency ablation of renal Tumors // Europ. Radiol. 2004. Vol. 14(8). P.1449-1455.Mahnken A.H., Rohde D., Brkovic D. et al. Percutaneous radiofrequency ablation of renal cell carcinoma: preliminary results // Acta Radiol. 2005. Vol. 46(2). P. 208- 214.Mahnken A.H., Rohde D., Brkovic D. et al. Percutaneous radiofrequency ablation of renal cell carcinoma: preliminary results // Acta Radiol. 2005. Vol. 46(2). P. 208- 214.Mayo-Smith W.W., Dupuy D.E., Parikh P.M. et al. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients // AJR Amer. J. Roentgenol. 2003. Vol. 180 (6). P.1503-1508.Mayo-Smith W.W., Dupuy D.E., Parikh P.M. et al. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients // AJR Amer. J. Roentgenol. 2003. Vol. 180 (6). P.1503-1508.Pavlovich C.P., Walther M.M., Choyke P.L. et al. Percutaneous radio frequency ablation of small renal tumors: initial results // J. Urol. 2002. Vol.167. P.10-15.Pavlovich C.P., Walther M.M., Choyke P.L. et al. Percutaneous radio frequency ablation of small renal tumors: initial results // J. Urol. 2002. Vol.167. P.10-15.Mondshine R.T., Owens S., Mondschein J.I., Cizman B., Stavropoulos S.W., Clark T.W. Combination embolization and radiofrequency ablation therapy for renal cell carcinoma in the setting of coexisting arterial disease // J. Vasc. Interv. Radiol. 2008 Apr; 19(4): 616-20.Mondshine R.T., Owens S., Mondschein J.I., Cizman B., Stavropoulos S.W., Clark T.W. Combination embolization and radiofrequency ablation therapy for renal cell carcinoma in the setting of coexisting arterial disease // J. Vasc. Interv. Radiol. 2008 Apr; 19(4): 616-20.Gebauer B., Werk M., Lopez-Hänninen E., Felix R., Althaus P. Radiofrequency ablation in combination with embolization in metachronous recurrent renal cancer in solitary kidney after contralateral tumor nephrectomy // Cardiovasc Interv. Radiol. 2007 Jul-Aug; 30(4): 644-9.Gebauer B., Werk M., Lopez-Hänninen E., Felix R., Althaus P. Radiofrequency ablation in combination with embolization in metachronous recurrent renal cancer in solitary kidney after contralateral tumor nephrectomy // Cardiovasc Interv. Radiol. 2007 Jul-Aug; 30(4): 644-9.Arima K., Yamakado K., Kinbara H., Nakatsuka A., Takeda K., Sugimura Y. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up // Int. J. Urol. 2007 Jul; 14(7): 585- 90; discussion 590.Arima K., Yamakado K., Kinbara H., Nakatsuka A., Takeda K., Sugimura Y. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up // Int. J. Urol. 2007 Jul; 14(7): 585- 90; discussion 590.Nakasone Y., Kawanaka K., Ikeda O., Tamura Y., Yamashita Y. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study // Acta Radiol. 2012 May 1; 53(4): 410-4. Epub 2012 Mar 5.Nakasone Y., Kawanaka K., Ikeda O., Tamura Y., Yamashita Y. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study // Acta Radiol. 2012 May 1; 53(4): 410-4. Epub 2012 Mar 5.

The authors declare that there are no conflicts of interest present.